The Burden of Radiation Exposure During Transcatheter Closure of Atrial Septal Defect.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 06 2021
Historique:
received: 19 01 2021
revised: 28 02 2021
accepted: 05 03 2021
pubmed: 25 3 2021
medline: 20 7 2021
entrez: 24 3 2021
Statut: ppublish

Résumé

Radiation reduction in the pediatric cardiac catheterization laboratory is well-suited for targeted quality improvement (QI) interventions. Transcatheter atrial septal defect (ASD) closure was chosen for this QI project based on a homogenous procedural population and inter-operator variability in radiation usage, with the aim to reduce radiation exposure during ASD device closure by 50% over 1 year. The aim for this project was defined and a Key Driver Diagram (KDD) was created with three domains for change: modification of procedural practice, reporting and monitoring/feedback, and team engagement. All patients undergoing attempted transcatheter ASD closure were considered for inclusion. The primary outcome, % reduction in median radiation dose (DAP/Kg), was determined through comparison with a historical cohort. Additional radiation metrics, procedural characteristics, and adverse events (AE) were compared to the historical cohort. Radiation exposure (DAP/kg) was reduced by 55% with a median dose reduction from 26 (15, 61) in a historical cohort to 12 (6, 22) in the intervention population (p <0.001). Fluoroscopy time and cine acquisition utilization significantly decreased. Procedure time, procedural success (defined as successful delivery of the device) and AE did not increase in the QI cohort. Successful practice changes included standardized procedural strategies to limit fluoroscopy and cine acquisition, improved fluoroscopic practice, engagement of the multidisciplinary team, and feedback with data reporting by electronic and in-person reminders. In conclusion, application of QI methodologies such as KDD with engagement of a multidisciplinary team can effectively reduce radiation in the pediatric catheterization laboratory.

Identifiants

pubmed: 33757782
pii: S0002-9149(21)00263-0
doi: 10.1016/j.amjcard.2021.03.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

126-131

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

David Joseph Harrison (DJ)

Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Lauren Shirley (L)

Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Jennifer Michaud (J)

Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Jose Rivera (J)

Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Brian Quinn (B)

Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Lisa Bergersen (L)

Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Nicola Maschietto (N)

Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: nicola.maschietto@cardio.chboston.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH